Mohammad Azab

(Dr. Mohammad Azab)

Currently holds positions in Astex Pharmaceuticals Inc and Xenon Pharmaceuticals Inc

Positions

Position Company Period
Chief Medical Officer Astex Pharmaceuticals Inc July 21, 2009 -
Independent Director Xenon Pharmaceuticals Inc Oct. 1, 2003 -
Mohammad Azab's trades of DURECT Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-25 2022-05-24
US DURECT Corp (DRRX)
B Purchase
5,000 +9.1%
0.39
USD 1,950 		5,000 +9.1% 0.39 USD 1,950
2022-05-25 2022-05-24
US DURECT Corp (DRRX)
B Purchase
10,000 +22.2%
0.39
USD 3,889 		10,000 +22.2% 0.39 USD 3,889
2022-05-25 2022-05-24
US DURECT Corp (DRRX)
B Purchase
5,000 +12.5%
0.38
USD 1,895 		5,000 +12.5% 0.38 USD 1,895
2022-05-25 2022-05-24
US DURECT Corp (DRRX)
B Purchase
5,000 +14.3%
0.39
USD 1,942 		5,000 +14.3% 0.39 USD 1,942
2022-05-25 2022-05-24
US DURECT Corp (DRRX)
B Purchase
5,000 +16.7%
0.39
USD 1,963 		5,000 +16.7% 0.39 USD 1,963
2022-05-18 2022-05-17
US DURECT Corp (DRRX)
B Purchase
1,800 +6.4%
0.42
USD 758 		1,800 +6.4% 0.42 USD 758
2022-05-18 2022-05-17
US DURECT Corp (DRRX)
B Purchase
8,900 +46.1%
0.42
USD 3,749 		8,900 +46.1% 0.42 USD 3,749
2022-05-18 2022-05-17
US DURECT Corp (DRRX)
B Purchase
9,300 +93.0%
0.42
USD 3,899 		9,300 +93.0% 0.42 USD 3,899
2022-05-18 2022-05-16
US DURECT Corp (DRRX)
B Purchase
10,000 +inf%
0.38
USD 3,767 		10,000 +inf% 0.38 USD 3,767
2019-09-17 2019-09-13
S Sale
23 -0.0%
9.31
USD 214 		23 -0.0% 9.31 USD 214
// ... existing code ... // ... rest of the file ...